The global biological and chemical indicators market is set to experience unprecedented expansion, with market research indicating a substantial increase in market value over the next decade. The market is expected to grow from USD 490.3 million in 2023 to a remarkable USD 866.9 million by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 5.9% throughout the forecast period.
This anticipated growth underscores the rising demand for biological and chemical indicators across various industries, driven by increasing regulatory standards, heightened awareness of safety protocols, and advancements in technology. These indicators play a crucial role in ensuring the effectiveness of sterilization processes and maintaining quality control in medical, pharmaceutical, and industrial applications.
Key Drivers of Market Growth:
- Stringent Regulatory Standards: The enforcement of stricter sterilization and safety regulations across industries is a significant driver of market expansion. Biological and chemical indicators are essential for verifying the efficacy of sterilization processes and ensuring compliance with industry standards.
- Technological Advancements: Innovations in indicator technology are enhancing accuracy, reliability, and ease of use. These advancements are contributing to the growing adoption of indicators in various applications.
- Rising Awareness: Increased awareness of the importance of safety and quality control in medical and pharmaceutical sectors is boosting the demand for effective biological and chemical indicators.
- Expanding Applications: The application of these indicators is broadening beyond traditional sectors, including new areas such as biotechnology and environmental monitoring, further fueling market growth.
As the market evolves, key players in the industry are expected to focus on developing innovative solutions to meet the growing demand and capitalize on emerging opportunities. This dynamic growth trajectory highlights the critical role of biological and chemical indicators in ensuring safety and quality across diverse applications.
Global Market Highlights:
- The United States is expected to lead the market, with an estimated value of USD 169.4 million by 2033, growing at a CAGR of 4.9%.
- Germany’s market is projected to reach USD 20.7 million by 2033, with a CAGR of 3.7%.
- The United Kingdom is expected to witness a CAGR of 6.0%, reaching USD 19.5 million by 2033.
- China’s market is anticipated to grow to USD 32.7 million by 2033, with a CAGR of 5.3%.
Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!
Latest Developments in the Biological and Chemical Indicators Industry:
- In 2020, Thermo Fisher Scientific, Inc. announced the acquisition of QIAGEN N.V. at approximately US$ 11.5 billion.
- In July 2020, 3M company announced Attest Mini Auto-reader 490M, a 24-minute in-house sterilization monitoring solution, the technology designed for dental professionals’ use.
Key Companies Profiled:
- The 3M Company
- Steris Plc.
- Thermo Fisher Scientific, Inc.
- Mesa Labs, Inc.
- McKesson Medical-Surgical Inc.
- Crosstex International, Inc.
- Propper Manufacturing Co., Inc.
- Terragene S.A.
- Andersen Products, Inc.
- Getinge AB
- GKE-GmbH
- Liofilchem S.r.l.
- Protak Scientific Ltd.
- ParaSure Limited
- Excelsior Scientific
- Siltex Australia Pvt. Ltd.
Biological and Chemical Indicators Industry by Category:
By Sterilization Type:
- Thermal Sterilization
- Steam Heat
- Dry Heat
- Chemical Sterilization
- Ethylene Oxide
- Hydrogen Peroxide
- Formaldehyde
- Radiation Sterilization
By Indicator Class:
- Biological Indicators
- Geobacillus stearothermophilus (GS) Spores
- Bacillus atrophaeus (BA) Spores
- Others
- Chemical Indicators
- Class 1 (Process)
- Class 4 (Multi-Variable)
- Class 2 (Specific-Use)
- Class 3 (Single-Variable)
- Class 5 (Integrating)
- Class 6 (Cycle Verification)
- Enzyme Indicators
By Packaging Form:
- Self-Contained BI
- Spore Suspension BI
- Strip and Disc BI
- Strip and Disc CI
- Others
By End User:
- Biopharma Industry
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Labs
- Research Lab
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle-East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube